← Open Payments lookup

MEGAN MORIARTY: Open Payments

NPI 1285306332 · LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,706 in 99 payments from 14 companies in 2025. Trend: 2023 $353 · 2024 $804 · 2025 $1,706

Food & beverage: $1,706
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.24$320
Vanda Pharmaceuticals Inc.13$319
Janssen Pharmaceuticals, Inc19$204
Axsome Therapeutics, Inc.7$162
E.R. Squibb & Sons, L.L.C.9$154
Neurocrine BioSciences, Inc.6$123
ABBVIE INC.4$90
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$88
Teva Pharmaceuticals USA, Inc.3$68
Alkermes, Inc.3$54

Products named: HETLIOZ, REXULTI, INVEGA SUSTENNA, Auvelity, COBENFY, INGREZZA, VRAYLAR, CAPLYTA.

Industry payments across IN — which companies pay providers there.